BlackRock, Inc. 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BlackRock Inc. BLK |
6,755,584 7.800% |
1,809,141 (+36.57%) |
Filing |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BlackRock Inc. BLK |
4,946,443 7.100% |
1,649,663 (+50.04%) |
Filing |
| 2022-07-08 4:57 pm Purchase |
2022-06-30 | 13G | Cogent Biosciences, Inc. COGT |
BlackRock Inc. BLK |
3,296,780 3.800% |
598,126 (+22.16%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Cogent Biosciences, Inc. COGT |
BlackRock Inc. BLK |
2,698,654 6.800% |
2,698,654 (New Position) |
Filing |